We are live on ! Find out more
SA

Sicart Associates Portfolio holdings

AUM $389M
1-Year Est. Return 42.46%
This Fund
S&P 500
This Quarter Est. Return
+5.64%
1 Year Est. Return
+42.46%
3 Year Est. Return
+89.06%
5 Year Est. Return
+118.65%
10 Year Est. Return
–
AUM
$138M
AUM Growth
-$6.49M
Cap. Flow
-$11.1M
Cap. Flow %
-8%
Top 10 Hldgs %
47.06%
Holding
111
New
11
Increased
35
Reduced
32
Closed
24

Top Buys

Rank Stock Value
1
PTEN icon
Patterson-UTI
PTEN
+$7.78M
2
IONS icon
Ionis Pharmaceuticals
IONS
+$3.91M
3
INTC icon
Intel
INTC
+$3.72M
4
EWQ icon
iShares MSCI France ETF
EWQ
+$1.74M
5
EWU icon
iShares MSCI United Kingdom ETF
EWU
+$1.7M

Top Sells

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$4.7M
2
UTEK
Ultratech Inc.
UTEK
+$4.61M
3
JCI icon
Johnson Controls International
JCI
+$2.15M
4
MPC icon
Marathon Petroleum
MPC
+$2.12M
5
AGN
Allergan plc
AGN
+$2.09M

Sector Composition

Rank Sector Weight
1 Technology 22.62%
2 Energy 20.47%
3 Healthcare 19.39%
4 Materials 5.38%
5 Industrials 4.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VZ icon
51
Verizon
VZ
$195B
$651K 0.47%
13,348
+2,500
+23% +$125K
CPB icon
52
Campbell Soup
CPB
$6.55B
$572K 0.41%
10,000
– –
ADP icon
53
Automatic Data Processing
ADP
$106B
$563K 0.41%
5,500
-500
-8% -$51K
VXF icon
54
Vanguard Extended Market ETF
VXF
$30.3B
$499K 0.36%
+5,000
New +$495K
RSPT icon
55
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.49B
$495K 0.36%
41,000
-40,000
-49% -$466K
RSPH icon
56
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$764M
$480K 0.35%
30,000
-30,000
-50% -$468K
CAT icon
57
Caterpillar
CAT
$375B
$464K 0.34%
5,000
– –
MAT icon
58
Mattel
MAT
$4.38B
$459K 0.33%
17,940
+530
+3% +$14.2K
PG icon
59
Procter & Gamble
PG
$336B
$451K 0.33%
5,019
-3,000
-37% -$266K
MA icon
60
Mastercard
MA
$506B
$450K 0.33%
4,000
-4,000
-50% -$438K
ADSK icon
61
Autodesk
ADSK
$49.5B
$432K 0.31%
5,000
-5,000
-50% -$418K
VXUS icon
62
Vanguard Total International Stock ETF
VXUS
$155B
$432K 0.31%
+8,700
New +$421K
B
63
Barrick Mining
B
$61.5B
$429K 0.31%
22,565
+1,800
+9% +$33.2K
ABT icon
64
Abbott
ABT
$183B
$426K 0.31%
9,585
+3,631
+61% +$157K
XBI icon
65
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$413K 0.3%
+5,960
New +$400K
SVC
66
Service Properties Trust
SVC
$1.04B
$407K 0.29%
2,580
+220
+9% +$34.5K
XL
67
DELISTED
XL Group Ltd.
XL
$399K 0.29%
10,000
– –
ALKS icon
68
Alkermes
ALKS
$8.22B
$380K 0.27%
6,500
-1,500
-19% -$85.1K
CL icon
69
Colgate-Palmolive
CL
$73.1B
$366K 0.26%
+5,000
New +$350K
COF icon
70
Capital One
COF
$128B
$347K 0.25%
+4,000
New +$356K
T icon
71
AT&T
T
$159B
$321K 0.23%
+10,216
New +$321K
F icon
72
Ford
F
$58.5B
$320K 0.23%
27,500
-15,000
-35% -$186K
MMM icon
73
3M
MMM
$90.9B
$320K 0.23%
+2,003
New +$307K
BGC icon
74
BGC Group
BGC
$5.52B
$311K 0.22%
42,607
+1,244
+3% +$8.94K
QCOM icon
75
Qualcomm
QCOM
$155B
$304K 0.22%
5,305
-10,200
-66% -$592K
1 2
3
4 5

Similar funds

AIM
Aigen Investment Management New York $389M AUM 16.77% 1-Year Est. Return
WCM
Winthrop Capital Management Carmel, Indiana $389M AUM 16.76% 1-Year Est. Return
HP
Hilltop Partners Mishawaka, Indiana $390M AUM 16.72% 1-Year Est. Return
P8IP
Pier 88 Investment Partners San Francisco, California $390M AUM 10.13% 1-Year Est. Return
PFPGI
Patriot Financial Partners GP II Radnor, Pennsylvania $388M AUM
PG
Prostatis Group Hanover, Maryland $391M AUM 20.37% 1-Year Est. Return
S
SimplyRich Carlsbad, California $391M AUM 24.42% 1-Year Est. Return
LHC
Little House Capital Braintree, Massachusetts $387M AUM 27.85% 1-Year Est. Return

Sicart Associates's Q1 2017 Portfolio in Review

As of Q1 2017, Sicart Associates held 111 positions worth $138M, down 4.5% from $145M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Sicart Associates withdrew a net $11.1M in Q1 2017, closing 24 positions and reducing 32 holdings. Its most notable exit was PTC Therapeutics, an estimated $4.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 17% a quarter earlier, followed by Energy and Healthcare.

Against the trend, Sicart Associates opened a new position in iShares MSCI France ETF worth $1.81M.

  • Sicart Associates's largest Q1 2017 buy was iShares MSCI France ETF: 68,450 shares worth $1.81M.
  • Sicart Associates added most to Patterson-UTI in Q1 2017, an estimated $7.78M increase.
  • Sicart Associates's biggest Q1 2017 reduction was Weyerhaeuser, cutting an estimated $1.79M.
  • Sicart Associates fully exited PTC Therapeutics in Q1 2017, selling an estimated $4.7M.
  • Sicart Associates's ten largest holdings make up 47% of its $138M portfolio in Q1 2017.
  • Sicart Associates opened 11 new positions and closed 24 in Q1 2017.
  • Sicart Associates's portfolio value fell 4.5% quarter-over-quarter to $138M.

Based on Sicart Associates's 13F filing for Q1 2017, filed 10 Apr 2017.